Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer.
Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer.
复制标题
DOI:
10.18632/oncotarget.22110
复制
发表时间:
2017-11-28
期刊:
影响因子:
--
通讯作者:
Iwata H
中科院分区:
文献类型:
--
作者:
Ogiya R;Niikura N;Kumaki N;Yasojima H;Iwasa T;Kanbayashi C;Oshitanai R;Tsuneizumi M;Watanabe KI;Matsui A;Fujisawa T;Saji S;Masuda N;Tokuda Y;Iwata H
Immune checkpoint inhibitors are reported to be effective in patients with brain metastases. However, detailed characteristics of the brain metastasis immune microenvironment remain unexplored. The median tumor-infiltrating lymphocyte (TIL) category in brain metastases was 5% (1–70%). In 46 pair-matched samples, the percentages of TILs were significantly higher in primary breast tumors than in brain metastases (paired t-test, P < 0.01). The numbers of CD4/CD8/Foxp3-positive cells were significantly higher in primary breast tumors than in brain metastases (paired t-test, P < 0.05 for all antibodies). In patients with triple-negative breast cancer specifically, low TIL numbers were associated with significantly shorter overall survival compared to high TIL numbers (log-rank test, P = 0.04). We retrospectively identified 107 patients with breast cancer and brain metastases who had undergone surgery between 2001 and 2012 at 8 institutions, and collected 191 samples including brain metastases alone and primary tumors with pair-matched brain metastasis samples. Hematoxylin and eosin-stained slides were evaluated for TILs and categorized according to the extent of staining. Immunohistochemistry for CD4, CD8, Foxp3, PD-L1, PD-L2, and HLA class I was also performed. There are significantly fewer TILs in brain metastases than in primary breast tumors.
登录
查看更多内容
DOI:
10.1007/s10555-016-9652-y
发表时间:
2017-03
期刊:
Cancer metastasis reviews
影响因子:
--
作者:
Khagi Y;Kurzrock R;Patel SP
通讯作者:
Patel SP
DOI:
10.1016/s1470-2045(16)30053-5
发表时间:
2016-07
期刊:
The Lancet. Oncology
影响因子:
--
作者:
Goldberg SB;Gettinger SN;Mahajan A;Chiang AC;Herbst RS;Sznol M;Tsiouris AJ;Cohen J;Vortmeyer A;Jilaveanu L;Yu J;Hegde U;Speaker S;Madura M;Ralabate A;Rivera A;Rowen E;Gerrish H;Yao X;Chiang V;Kluger HM
通讯作者:
Kluger HM
影响因子:
50.3
作者:
Tang H;Wang Y;Chlewicki LK;Zhang Y;Guo J;Liang W;Wang J;Wang X;Fu YX
通讯作者:
Fu YX
影响因子:
45.3
作者:
Nanda, Rita;Chow, Laura Q. M.;Buisseret, Laurence
通讯作者:
Buisseret, Laurence
影响因子:
--
作者:
Harter PN;Bernatz S;Scholz A;Zeiner PS;Zinke J;Kiyose M;Blasel S;Beschorner R;Senft C;Bender B;Ronellenfitsch MW;Wikman H;Glatzel M;Meinhardt M;Juratli TA;Steinbach JP;Plate KH;Wischhusen J;Weide B;Mittelbronn M
通讯作者:
Mittelbronn M